Inmune Bio, Inc. (INMB) Form 8-K — Jun 17, 2026
$INMBForm 8-KItems 5.02, 5.07, 9.01Filed Jun 17, 2026, 8:00 AM ET0001213900-26-069611Original filing
Inmune Bio Inc. announced the results of its 2026 annual meeting of stockholders, held on June 16, 2026. Stockholders elected five nominees to the board of directors, including J. Kelly Ganjei, Tim Schroeder, Scott Juda, and Marcia Allen, to serve until the next annual meeting.
Key figures
- Shares Outstanding
- 26585258
- Total Incentive Plan Shares
- 9158525
- Evergreen Provision Percentage
- 10.0%
Price after filing
1 day: +11.5%7 days: +3.8%30 days: +59.2%
Close on the filing date to close N calendar days later (from $1.30). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.